Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
31%
ALSO IN IHE
IHE
36
HOLDINGS
43%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus IHE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 8.3% | 25.5% | 8.3% |
|
MERCK & CO. INC. | 6.9% | 4.6% | 4.6% |
|
PFIZER INC | 7.3% | 4.6% | 4.6% |
|
BRISTOL-MYERS SQUIBB CO | 6.1% | 4.2% | 4.2% |
|
VIATRIS, INC. | 4.1% | 4.9% | 4.1% |
FTXH Overweight Relative to IHE
|
ABBVIE INC | 7.5% |
|
GILEAD SCIENCES INC | 4.1% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
AMGEN INC | 3.7% |
|
BIOGEN IDEC INC | 3.7% |
|
REGENERON PHARMACEUTICALS | 3.2% |
|
PFIZER INC | 2.7% |
|
MEDPACE HOLDINGS, INC. | 2.6% |
|
MERCK & CO. INC. | 2.3% |
|
CHARLES RIVER LABORATORIES | 2.0% |
FTXH Underweight Relative to IHE
|
JOHNSON & JOHNSON | -17.2% |
|
ELI LILLY & CO | -15.0% |
|
ROYALTY PHARMA PLC CLASS A | -5.0% |
|
CORCEPT THERAPEUTICS INC | -2.8% |
|
AXSOME THERAPEUTICS, INC. | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.4% |
|
ELANCO ANIMAL HEALTH, INC. | -1.4% |
|
SUPERNUS PHARMACEUTICALS INC | -1.2% |
|
PRESTIGE BRANDS HOLDINGS INC | -1.0% |
|
TARSUS PHARMACEUTICALS, INC. | -0.9% |